Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David H. Mack is active.

Publication


Featured researches published by David H. Mack.


Cell | 1994

Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells.

C.Alexander Turner; David H. Mack; Mark M. Davis

We describe a novel gene, Blimp-1 (for B lymphocyte-induced maturation protein), transcripts of which are rapidly induced during the differentiation of B lymphocytes into immunoglobulin secretory cells and whose expression is characteristic of late B and plasma cell lines. The 856 amino acid open reading frame contains five Krüppel-type zinc finger motifs and proline-rich and acidic regions similar to those of known transcription factors. Serological studies show an approximately 100 kd protein that localizes to the nucleus. Stable or transient transfection of Blimp-1 into B cell lymphoma lines leads to the expression of many of the phenotypic changes associated with B cell differentiation into an early plasma cell stage, including induction of J chain message and immunoglobulin secretion, up-regulation of Syndecan-1, and increased cell size and granularity. Thus, Blimp-1 appears to be a pleiotropic regulatory factor capable of at least partially driving the terminal differentiation of B cells.


Proceedings of the National Academy of Sciences of the United States of America | 2001

Attributes of gammadelta intraepithelial lymphocytes as suggested by their transcriptional profile.

Aude M. Fahrer; Yves Konigshofer; Elizabeth M. Kerr; Ghassan Ghandour; David H. Mack; Mark M. Davis; Yueh-hsiu Chien

γδ T lymphocytes in the intestinal intraepithelial layer (γδ IELs) are thought to contribute to immune competence, but their actual function remains poorly understood. Here we used DNA microarrays to study the gene expression profile of γδ IELs in a Yersinia infection system to better define their roles. To validate this approach, mesenteric lymph node CD8+ αβ T cells were similarly analyzed. The transcription profiles show that, whereas lymph node CD8+ αβ T cells must be activated to become cytotoxic effectors, γδ IELs are constitutively activated and appear to use different signaling cascades. Our data suggest that γδ IELs may respond efficiently to a broad range of pathological situations irrespective of their diverse T cell antigen receptor repertoire. γδ IELs may modulate local immune responses and participate in intestinal lipid metabolism, cholesterol homeostasis, and physiology. This study provides a strong basis for further investigations of the roles of these cells as well as mucosal immune defense in general.


Journal of Immunology | 2010

Pillars Article: Blimp-1, a Novel Zinc Finger-Containing Protein That Can Drive the Maturation of B Lymphocytes into Immunoglobulin-Secreting Cells. Cell. 1994. 77: 297–306

C.Alexander Turner; David H. Mack; Mark M. Davis

We describe a novel gene, Blimp-1 (for B lymphocyte-induced maturation protein), transcripts of which are rapidly induced during the differentiation of B lymphocytes into immunoglobulin secretory cells and whose expression is characteristic of late B and plasma cell lines. The 856 amino acid open reading frame contains five Kruppel-type zlnc finger motifs and proline-rich and acidic regions similar to those of known transcription factors. Serological studies show an ∼ 100 kd protein that localizes to the nucleus. Stable or transient transfection of Blimp-1 into B cell lymphoma lines leads to the expression of many of the phenotypic changes associated with B cell differentiation into an early plasma cell stage, including induction of J chain message and immunoglobulin secretion, up-regulation of Syndecan-1, and increased cell size and granularity. Thus, Blimp-1 appears to be a pleiotropic regulatory factor capable of at least partially driving the terminal differentiation of B cells.


Nature | 1993

Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53

David H. Mack; Jai V. Vartikar; James M. Pipas; Laimonis A. Laimins


Archive | 2002

Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer

Daniel E. H. Afar; Natasha Aziz; Wendy M. Ginsburg; Kurt C. Gish; Richard Glynne; Peter Hevezi; David H. Mack; Richard Murray; Susan R. Watson; Keith E. Wilson; Albert Zlotnik


Archive | 2002

Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer

David H. Mack; Kurt C. Gish; Daniel E. H. Afar


Immunological Reviews | 2000

B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays.

Richard Glynne; Ghandour G; Rayner J; David H. Mack; Christopher C. Goodnow


Archive | 2002

Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer

Daniel E. H. Afar; David B. Agus; David H. Mack


Archive | 2003

Methods of prognosis of prostate cancer

Daniel E. H. Afar; Susan M. Henshall; Jordan Hiller; David H. Mack; Robert L. Sutherland


Archive | 2003

Methods of detecting colorectal cancer

Kurt C. Gish; David H. Mack; Keith E. Wilson; Sanford D. Markowitz

Collaboration


Dive into the David H. Mack's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Richard Glynne

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge